Join Health Affairs on December 11 for a virtual event examining private equity’s impact on the practice of medicine.

We aim to provide transparency in how Elevance Health plans address variations in clinical practices to ensure safe, ...

Data fragmentation and inefficiency are most evident in the quality reporting approach currently used for accountable care ...

Taylor holds a bachelor’s degree from the University of Washington (UW) School of Engineering in technical communication and a master’s degree in clinical informatics and patient-centered technology ...

Geoffrey Crawford serves as Staff Vice President of Medical Policy (US) for The Elevance Health Companies, Inc.

Margolis Center for Health Policy to the pod to discuss her recent Forefront article focused on how ACO REACH enabled ACOs to ...

The majority of promotional expenditures are invested in drug samples, one of the industry’s most important marketing tactics ...

In late August 2025, CMS released Performance Year (PY) 2024 data for the Medicare Shared Savings Program (MSSP). This marked ...

The Inflation Reduction Act (IRA) of 2022 mandates price negotiations for certain drugs under Medicare, shortening the exclusivity period historically used to recoup research and development ...

Audrey Ford, MS, is a Policy Research Associate on the Health Care Transformation team at Duke-Margolis and supports projects on the Medicare accountable care portfol ...

Merna Shohdy is a medical student at the City University of New York School of Medicine and an affiliated researcher at Memorial Sloan Kettering Cancer Center.

Despite Medicaid’s importance as a payer and source of coverage for mental health care, relatively little is known about how prevalence, access, and quality might vary among Medicaid beneficiaries.